In tackling the thorny question of whether human genes can be patented, the Supreme Court could issue a ruling that prevents companies from getting patents on certain DNA molecules and other isolated molecules, such as therapeutic proteins and antibiotics.
The court will take up the question when it hears oral arguments April 15 in The Association for Molecular Pathology...